U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07039929) titled 'Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants' on June 18.
Brief Summary: This study will be conducted to assess the safety, tolerability, and pharmacokinetics of INCB000631 when administered orally to healthy adult participants.
Study Start Date: July 28
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: INCB000631
Oral; Tablet
DRUG: Placebo
Oral; Tablet
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Incyte Corporation
Disclaimer: Curated by HT Syndication....